Gregory Carlson, NP
Gerontology · Coachella, CANPI 1740822576
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,586 and has fallen 64.4% since, to $920 in 2025. Among gerontology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $28.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$767
- GSK$396
- AstraZeneca$365
- Dexcom, Inc.$347
- Astellas Pharma US Inc$343
- Amgen$337
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,877100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $767 |
| GSK | 18 | $396 |
| AstraZeneca | 9 | $365 |
| Dexcom, Inc. | 7 | $347 |
| Astellas Pharma US Inc | 9 | $343 |
| Amgen | 9 | $337 |
| Eisai Inc. | 5 | $239 |
| Novo Nordisk | 7 | $232 |
| Exact Sciences | 12 | $205 |
| Medtronic | 3 | $187 |
| AbbVie | 10 | $184 |
| Sumitomo Pharma America, Inc. | 9 | $164 |
| Lilly USA, LLC | 8 | $145 |
| Corium, LLC | 3 | $144 |
| Bayer | 6 | $118 |
| Boehringer Ingelheim | 4 | $99 |
| Pfizer | 4 | $99 |
| Sanofi-aventis U.S. LLC | 4 | $86 |
| Arbor Pharmaceuticals, Inc. | 4 | $68 |
| Dynavax Technologies Corporation | 3 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| Johnson & Johnson | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Avvisto Therapeutics, LLC | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Viatris Specialty LLC | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Bioventus LLC | 1 | $17 |
| OPKO Pharmaceuticals, LLC | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$532
- Veozah$239
- INTELLIS ADAPTIVESTIM$153
- DEXCOM G7 GSS (161)$138
- BREZTRI$125
- AIRSUPRA$123
- EVENITY$122
- Ozempic$121
- AREXVY$113
- DEXCOM G6 TRANSMITTER$112
- ADLARITY$112
- Leqembi$112
- Repatha$101
How this compares
$4,877 in reported general payments places this provider in the 90th percentile of 348 gerontology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $95,778 |
| FarxigaDapagliflozin Propanediol | 18 | $17,900 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $17,786 |
| MyrbetriqMirabegron | 12 | $16,686 |
| EliquisApixaban | 15 | $16,598 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $13,396 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $9,797 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,337 |
| Gabapentin | 109 | $2,110 |
| Testosterone Cypionate | 38 | $1,655 |
| Rosuvastatin Calcium | 130 | $1,654 |
| Sucralfate | 17 | $1,429 |
| Testosterone | 13 | $1,355 |
| Tamsulosin Hcl | 86 | $1,287 |
| Montelukast Sodium | 193 | $1,233 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $232 | $95,77880 claims |
| AstraZenecaFarxiga | $365 | $17,90018 claims |
| GSKTrelegy Ellipta | $396 | $17,78623 claims |
| Astellas Pharma US IncMyrbetriq | $343 | $16,68612 claims |
| PfizerEliquis | $99 | $16,59815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 348 gerontology providers in California.
Other gerontology in Coachella
- Lovely IsraelSanta Monica$95K
- Leslie TarlowLos Angeles$58K
- Christine PartamianPorter Ranch$41K
- Elsa Pineda-FloresLos Angeles$24K
- Maria MottaDuarte$23K
- Daniel ChiuOrange$17K
- Katiaryna KulinichChula Vista$15K
- Nataliya OsorioRiverside$13K
- Anne Marie de Joya ReeveDuarte$11K
- Wendy AlmonteLemoore$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.